BioPharma Services is a medical research company committed to delivering excellence in early stage clinical research which helps to provide affordable and safe medicines to every patient in need.
Sign up below to be informed and matched to our current or upcoming studies.
If you’re interested in an upcoming trial or would like to be informed of future trials, you can contact our Recruiting Call Centre and register/prescreen with us. Upon completing your registration we will provide you with the details of the study and assess if you qualify for the study on a preliminary basis (pre-screening).
If you are deemed eligible during your pre-screening (preliminary) evaluation, we will schedule you for a screening appointment. During this visit, you will participate in an informed consent session as well as the following medical assessments/measurements (these may vary based on the study requirements): body mass index (BMI), electrocardiogram (ECG)*, blood pressure, heart rate, respiratory rate, body temperature, physical examination, medical history review, alcohol test, blood test(s), urine test(s).
*ECG: An ECG (electrocardiogram) records the electrical activity of your heart. It provides information about your heart rate and rhythm.
If you are deemed eligible based on the results of your medical screening visit, you will contacted by the Results Coordinator. We will usually call you within 5 business days of your medical screening appointment. This may vary.
If you are assigned to a study, you will need to be prepared for your visits. This requires you to be available for the study visits based on the dates and times listed in the study schedule, following the study restrictions and arriving at the site in a timely manner with your personal belongings.
You will receive the full study compensation upon completion of all the study visits. This compensation may be broken down into partial payments depending on the overall duration of the study. Penalties and deductions may be applied for lateness, missed visits or non-compliances (as outlined in the Informed Consent Form). The compensation is provided on a pro-rated basis (i.e. you will be compensated for all completed visits according to the payment schedule).
What happened?
On November 20, 2025, BioPharma Services Inc. (BPSI) experienced a ransomware attack that resulted in the unauthorized encryption of several servers. Upon discovering this incident, we initiated BPSI’s incident response protocols and deployed countermeasures to prevent further unauthorized access and isolated impacted systems. We also launched a thorough investigation into the cause and extent of the incident in collaboration with third-party cybersecurity experts. At the time, no evidence was uncovered of any personal health information being accessed or removed from BPSI’s network.
Unfortunately, on February 3, 2026, we discovered that data from the November 2025 incident was posted on a dark web site. We immediately downloaded and reviewed the data to identify what it contained and who may be impacted.
Our review indicated that the information involved included study participants’ name, home address, date of birth, email address, phone number, gender, income, race/ethnicity, and health information pertaining to screening for and participation in clinical trials facilitated by BPSI. The impacted data types vary by individual.
The vast majority of impacted study participants are Ontario residents but, from time to time, we have had a relatively small number of participants from other provinces participate in trials conducted in Ontario. Those individuals may have been impacted by this incident as well.
What has been done?
We have confidence in the countermeasures taken and the security of our systems and feel we have done everything necessary at this time to continue operating safely and protect the sensitive personal information in our custody. We are actively monitoring our systems to help defend against future attacks of this nature and have further enhanced our cybersecurity safeguards. We have implemented several advanced measures already and will continue evaluating opportunities to do so, where appropriate, on an ongoing basis. We take the privacy and security of the information in our care very seriously.
BPSI has reported this matter to the Information and Privacy Commissioner of Ontario as well as law enforcement.
What can I do?
It is always recommended to be vigilant and report any suspicious activity to the appropriate authorities. Tips and resources for protecting your identity are available at https://www.priv.gc.ca/en/privacy-topics/identities/identity-theft/guide_idt/.
Who should I contact if I have questions?
If you have questions regarding this notice, please contact us at privacy@well.company. When reaching out, kindly provide your name and phone number so we can assist you promptly.
While no action is required on your part as we have already reported the incident, you have the right to complain to the Information and Privacy Commissioner of Ontario (IPC). You can contact the IPC by phone at 416-326-3333 or toll-free at 1-800-387-0073, or by email at info@ipc.on.ca.
Sign-up to receive latest news, updates and marketing emails from BioPharma Services!
You can unsubscribe at any time by clicking the unsubscribe button in the footer of the emails you receive.